Charles Explorer logo
🇬🇧

Ferritin, oxidative stress and coronary atherosclerosis

Publication at Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine |
2004

Abstract

Background and Aim: In the recent years several studies showed the association between body iron stores, represented by serum ferritin, and atherosclerosis. It was proposed that iron bound to ferritin catalyzes the formation of highly reactive forms of oxygen free radicals which subsequently cause the oxidative modification of atherogenic lipoproteins.

Aim of our study was to compare serum ferritin concentrations and certain markers of oxidative stress in patients with and without coronarographically assessed coronary vascular disease. Methods and Results: Measurements were performed in 216 subjects at the age of 35 - 60 years.

The patient group included 76 patients with coronarographically assessed coronary vascular disease (CVD) (mean age 51.16 +- 5.713 years) and 140 healthy controls (mean age 50.21 +- 5.331 years). The plasma concentration of ferritin was higher in patients (169.04 +- 63.899 g/l) than controls (87.70 +- 41.394 g/l), p < 0.001.

The group of patients revealed significantly lower plasma concentrations of anti-oxLDL antibodies, nitrites/nitrates, tocopherol and high density lipoprotein cholesterol (HDL-cholesterol) than controls; on the contrary patients had significantly higher concentrations of hemoglobin, thrombocytes and triacylglycerols. In the whole cohort of investigated subjects, ferritin correlated positively with retinol, body mass index (BMI), total-cholesterol, triacylglycerols, low density lipoprotein cholesterol (LDL-cholesterol), blood glucose, creatinine, uric acid, alaninaminotransferase (ALT), aspartateaminotransferase (AST), hematocrite, erythrocytes, with occurrence of CVD and with sex.

Inverse correlation was observed between ferritin and HDL-cholesterol. Conclusions: Our observations are consistent with the hypothesis that high stored iron levels, measured by serum ferritin concentrations, may contribute to the oxidative stress and thus elevate the risk for development of CVD.